Deutsche Bank is bookrunner; JMP Securities, Oppenheimer assist
By Devika Patel
Knoxville, Tenn., Oct. 1 – VBL Therapeutics said it priced its $40 million initial public offering of stock with a $6 million greenshoe on Tuesday.
The company will sell 6,666,667 ordinary shares at $6.00 per share.
Deutsche Bank Securities is the bookrunning manager.
Settlement is expected Oct. 6.
Proceeds will be used for clinical trials, studies, research and development and other general corporate purposes.
The biotechnology company is based in Tel Aviv. The company intends to list its common stock on the Nasdaq stock exchange under the symbol “VBLT.”
| Issuer: | VBL Therapeutics
|
| Issue: | Ordinary stock
|
| Amount: | $40 million
|
| Greenshoe: | $6 million
|
| Shares: | 6,666,667
|
| Price: | $6.00
|
| Warrants: | No
|
| Bookrunner: | Deutsche Bank Securities
|
| Co-managers: | JMP Securities and Oppenheimer & Co.
|
| Pricing date: | Sept. 30
|
| Settlement date: | Oct. 6
|
| Stock exchange: | Nasdaq: VBLT
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
